Johnston Kylie Nicole, Potter Adrian James, Phillips Anna Caroline
School of Health Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia.
Int J Chron Obstruct Pulmon Dis. 2017 Oct 9;12:2849-2857. doi: 10.2147/COPD.S143179. eCollection 2017.
Field exercise tests (eg, 6-minute walk test [6MWT]) are important measures of functional exercise capacity in people with COPD. Shorter tests such as the 2-minute walk test (2MWT) may offer advantages in some populations but lack information about responsiveness to change. This study examined responsiveness, minimal important difference (MID), test-retest reliability, and construct validity of the 2MWT in people with stable COPD attending outpatient pulmonary rehabilitation (PR).
At pre-PR assessment, study participants completed a 2MWT twice in addition to usual measures (6MWT and Chronic Respiratory Questionnaire). At post-PR assessment following a standard PR program, measures were repeated and global rating of change scores obtained (patient and therapist). Pre-post program change scores were examined for correlations with change in 2-minute walk distance (2MWD) and used (where ≥0.3) to estimate the MID through anchor-based methods. Distribution-based estimates based on standard error of measurement were examined. Test-retest reliability (intraclass correlation coefficient [ICC] and Bland-Altman agreement) and validity (Pearson correlation with 6-minute walk distance [6MWD]) were reported.
Fifty-nine people (28 men) with stable COPD, mean age 68 years (SD 10 years), and percentage predicted forced expiratory volume in 1 second 48% (SD 20%) attended pre-PR assessment. Test-retest ICC for same-session 2MWD was 0.985. A mean difference of 2.4 m (95% confidence interval [CI] 0.7-4.0 m, =0.006) occurred between the first and second trials. 2MWD and 6MWD were highly correlated (=0.87, <0.001). Forty-one participants completed PR and were included in responsiveness and MID analysis. Mean 2MWD improved significantly post-PR (8.8 m, 95% CI 3.6-14 m, =0.001). The MID in 2MWD, anchored against clinically meaningful change in 6MWD, was 5.5 m (area under curve =0.81, =0.001). Distribution-based methods estimated an MID of 4 m.
Change in 2MWD of at least 5.5 m following a PR program corresponded to a clinically meaningful change. A practice test is recommended due to learning effects.
现场运动测试(如6分钟步行试验[6MWT])是慢性阻塞性肺疾病(COPD)患者功能运动能力的重要指标。较短的测试如2分钟步行试验(2MWT)在某些人群中可能具有优势,但缺乏关于变化反应性的信息。本研究探讨了2MWT在接受门诊肺康复(PR)的稳定期COPD患者中的反应性、最小重要差异(MID)、重测信度和结构效度。
在PR评估前,研究参与者除了进行常规测量(6MWT和慢性呼吸问卷)外,还完成了两次2MWT。在标准PR计划后的PR评估后,重复测量并获得变化的总体评分(患者和治疗师)。检查计划前后的变化分数与2分钟步行距离(2MWD)变化的相关性,并(当≥0.3时)用于通过基于锚定的方法估计MID。检查基于测量标准误差的基于分布的估计。报告重测信度(组内相关系数[ICC]和Bland-Altman一致性)和效度(与6分钟步行距离[6MWD]的Pearson相关性)。
59名(28名男性)稳定期COPD患者,平均年龄68岁(标准差10岁),1秒用力呼气量预测值百分比为48%(标准差20%),参加了PR评估前的检查。同次2MWD的重测ICC为0.985。第一次和第二次试验之间的平均差异为2.4 m(95%置信区间[CI] 0.7 - 4.0 m,P = 0.006)。2MWD和6MWD高度相关(r = 0.87,P < 0.001)。41名参与者完成了PR并纳入反应性和MID分析。PR后2MWD平均显著改善(8.8 m,95% CI 3.6 - 14 m,P = 0.001)。以6MWD的临床有意义变化为锚定的2MWD的MID为5.5 m(曲线下面积 = 0.81,P = 0.001)。基于分布的方法估计MID为4 m。
PR计划后2MWD至少变化5.5 m对应于临床有意义的变化。由于存在学习效应,建议进行练习测试。